Quick Search
Ubiquinone / Coenzyme Q10 is gradually decomposed and colored by light.
Ubiquinone / Coenzyme Q10 is a quinone that is found throughout the human body in cell membranes, primarily in mitochondrial membranes, with the highest levels in the heart, lungs, liver, kidneys, spleen, pancreas, and adrenal glands.
Ubiquinone / Coenzyme Q10 exists in three redox states: fully oxidized (CoQ10/ubiquinone), partially reduced (semiquinone or ubisemiquinone), and fully reduced (ubiquinol; ).
CAS Number: 303-98-0
Molecular Formula: C59H90O4
Molecular Weight: 863.34
EINECS Number: 206-147-9
Synonyms: Coenzyme Q10, ubidecarenone, 303-98-0, CoQ10, ubiquinone-10, Ubiquinone 50, Ubiquinone Q10, Ubidecarenona, Bio-Quinone Q10, Aqua Q10, Unispheres Q 10, Ubidecarenonum, PureSorb Q 40, Adelir, Oristar ubq, co-enzyme Q10, Coenzyme q-199, CoQ 10, API-31510, Q 199, 2-((2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione, DTXSID6046054, EJ27X76M46, Ubidecarenone for system suitability, BPM-31510, Bpm31510, NSC-140865, API 31510, NSC-140665, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl]-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione, DTXCID4026054, CHEBI:46245, NSC140865, 2-((all-E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-p-benzoquinone, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl]-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione, vitamin Q10, 2-((2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione, 2,3-dimethoxy-5-methyl-6-decaprenylbenzoquinone, RefChem:56188, CoQ10 200mg, Co-Q10, C01EB09, CO Q 10, (2E,6E,10E,14E,18E,22E,26E,30E,34E,38E)-2-(3,7,11,15,19,23,27,31,35,39-Decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl)-5,6-dimethoxy-3-methyl-1,4-benzoquinone, 2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecanyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione, Ubiquinone 10, Neuquinon, Justquinon, Neuquinone, Emitolon, Heartcin, Inokiten, Terekol, Udekinon, Coenzyme Q-10, Luvacor, Coenzyme Q 10, Vitamin Q, Ubidecarenonum [Latin], CoenzymeQ10, coenzyme-Q10, MFCD00042919, NSC 140865, all-trans-ubiquinone, Ube-Q, (all-E)-2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-2,5-Cyclohexadiene-1,4-dione, Ubidecarenone [INN:BAN:JAN:NF], Q-Gel 100, NCGC00159429-02, UBIDECARENONE [MART.], Q 10AA, C59H90O4, 2,5-Cyclohexadiene-1,4-dione, 2-((2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl, 2,5-Cyclohexadiene-1,4-dione, 2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-, (all-E)-, 2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-p-benzoquinone, p-Benzoquinone, 2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-, Bio-Quinon, Coenzyme Q(sub 10), Ubidecarenona [Spanish], CoQ(sub 10), Ubiquinone Q(sub 10), CAS-303-98-0, CoQ10;Ubiquinone-10, CCRIS 9016, Co-enzyme Q-10, EINECS 206-147-9, Co Q10, unbiquinone, Armolipid, Kudesan, Mitocor, Akvion, UNII-EJ27X76M46, Liquid-Q, Ubidecarenone CRS, Ubiquinone-Q10, ubiquinone(10), NCGC00095322-03, KanekaQ10, Ubiquinone 10, Ubiquinone 50, 5-((2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl)-2,3-dimethoxy-6-methylcyclohexa-2,5-diene-1,4-dione, U10, Li-Q-Sorb, Q-Gel, Adelir (TN), Kaneka Q10, BP31510, CoQ10; Ubiquinone-10, Coenzyme Q10 (Standard), Aqua Q 10L10, UBIDECARENONE [DSC], UBIDECARENONE [INN], UBIDECARENONE [JAN], Ubidecarenone (JP18/INN), SCHEMBL19858, MLS000028745, Ubiquinone-10; Ubidecarenone, UBIQUINONE 50 [MI], Coenzyme Q10 fermented powder, Ubidecarenone (Coenzyme Q10), 303-98-0 (Unlabeled), COENZYME Q10 [VANDF], UBIDECARENONE [USP-RS], UBIDECARENONE [WHO-DD], CHEMBL454801, orb1225371, orb1305009, orb3139482, HY-N0111R, EX-A973, Coenzyme Q10, analytical standard, GLXC-10860, HY-N0111, Tox21_111660, Tox21_113394, UBIDECARENONE [EP MONOGRAPH], EBC-24049, LMPR02010001, MSK158299, SBB057402, Coenzyme Q10, >=98% (HPLC), AKOS015897104, AKOS015951232, AC-4352, DB09270, FC20535, Ubidecarenone for system suitability CRS, NCGC00159429-13, NCGC00159429-14, 2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-tetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl)-5,6-dimethoxy-3-methyl-[1,4]benzoquinone, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl]-5,6-dimethoxy-3-methyl-1,4-benzoquinone, AS-13341, LS-15517, Q 10, SMR000058651, SY051283, C1971, CS-0007796, NS00014191, ST50999657, D01065, EN300-21680292, Q321285, BRD-K75043328-001-03-4, BRD-K75043328-001-04-2, BRD-K75043328-001-05-9, UBIDECARENONE FOR SYSTEM SUITABILITY [USP-RS], Ubidecarenone, European Pharmacopoeia (EP) Reference Standard, Ubidecarenone, United States Pharmacopeia (USP) Reference Standard, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39, 2-DECA(3-METHYLBUT-2-ENYLENE)-5,6-DIMETHOXY-3-METHYL-P-BENZOQUINONE, Ubidecarenone for system suitability, European Pharmacopoeia (EP) Reference Standard, Ubidecarenone for System Suitability, United States Pharmacopeia (USP) Reference Standard, (all-E)-2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31-octamethyl-2,6,10,14,18,22,26,30-dotriacontaoctaenyl)-2,5-Cyclohexadiene-1,4-dione, (all-E)-2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione, 2,4-dione, 2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-, 2,4-dione, 2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-, (all-E)-, 2,5-Cyclohexadiene-1,4-dione, 2-((2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaen-1-yl)-5,6-dimethoxy-3-methyl-, 2,5-Cyclohexadiene-1,4-dione, 2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-, (all trans)-, 2-((all-E)-3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione, 2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-p-benzoquinone, (all trans)-, 2-(3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2E,6E,10E,14E,18E,22E,26E,30E,34E,38-decaenyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl]-5,6-dimethoxy-3-methyl- 2,5-Cyclohexadiene-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl]-5,6-dimethoxy-3-methylbenzo-1,4-quinone #, 2-[(all-E)-3,7,11,15,19,23,27,31,35,39-Decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl]-5,6-dimethoxy-3-methylbenzene-1,4-dione, Coenzyme Q10 is a powerful antioxidant that is naturally found in the cells. It acts as a free radical neutraliser., p-Benzoquinone,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-;2,5-cyclohexadiene-1,4-dione,2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,;22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-1(all-e)-1;5-Cyclohexadiene-1,4-dione,2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-t2;coenzymeq(sub10);coq(sub10);neuquinon;p-benzoquinone,2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30
Ubiquinone / Coenzyme Q10 occurs as a yellow to orange crystalline powder.
Ubiquinone / Coenzyme Q10 is odorless and has no taste.
Ubiquinone / Coenzyme Q10 is soluble in diethyl ether, very slightly soluble in ethanol (99.5), and practically insoluble in water.
Ubiquinone / Coenzyme Q10 acts as an electron shuttle in the electron transport chain via its reduction to ubiquinol between mitochondrial complexes I and II, also known as NADH dehydrogenase and succinate dehydrogenase, respectively, and mitochondrial complex III, also known as cytochrome bc1 complex.
Ubiquinone / Coenzyme Q10 is also reduced to ubiquinol by ferroptosis suppressor protein 1 (FSP1) with NADPH as a cofactor, and ubiquinol traps lipid peroxyl radicals and inhibits lipid peroxidation helping to prevent ferroptosis.
Mutations in genes encoding enzymes involved in CoQ10 biosynthesis lead to primary CoQ10 deficiency, which is characterized by encephalopathy, cerebellar ataxia, infantile multisystemic form, nephropathy, and isolated myopathy.
Secondary CoQ10 deficiency, induced by non-genetic impaired CoQ10 biosynthesis, insufficient CoQ10 intake, or excessive CoQ10 utilization, has been observed in a variety of conditions, including ataxia-oculomotor-apraxia 1 (AOA1), mitochondrial diseases, and hypercholesteremia with statin therapy.
Ubiquinone / Coenzyme Q10 is a small molecule lipid-soluble quinone compounds widely found in plant and animal cells, its structure is similar to the structure of vitamin K, used alone or in combination with vitamin E as a powerful antioxidant.
Ubiquinone / Coenzyme Q10 is required for energy generation (ATP) circulation.
Ubiquinone / Coenzyme Q10 promotes phosphorylation reaction and protect the structural integrity of the biofilm oxidation function.
Ubiquinone / Coenzyme Q10 of different sources are different with its side chain prenyl units number,
Ubiquinone / Coenzyme Q10 of humans and mammals are 10 prenyl units, thus it is called Ubidecarenone.
Ubiquinone / Coenzyme Q10 plays an important role in proton translocation in vivo respiratory chain and electron transfer , it is the cell respiration and cell metabolism activator, and also an important antioxidant and non-specific immune enhancer.
Modern biology study found that excess free radicals in the body can cause damage to the genetic material of the cell membrane, and macro manifested as aging, cancer and other symptoms.
Enzymes are large proteins, enzymes need some small molecules to help in exercising some functions , these substances are called "coenzyme."
Ubiquinone / Coenzyme Q10 exists in the mitochondria within the cells.
Mitochondria are the place to produce energy in cells, many enzymes and other molecules are involved in the energy production process, and Ubidecarenone is one of the indispensable one.
In the organs with more energy consumption in the human body , the content of Ubidecarenone will be relatively high, such as heart, liver, kidney, kidney, spleen, pancreas, adrenal, the content is particularly rich.
The total body content of Ubidecarenone is only 500-1500mg, the content changes with age, it decreased for most people after the age of 20.
Lack of Ubidecarenone are usually caused heart failure, gum disease, arrhythmias, stroke, hypertension (blood pressure, food), heart disease, arteriosclerosis, cancer, Parkinson's disease, muscular dystrophy, AIDS.
Ubiquinone / Coenzyme Q10 can successfully prevent and treat these diseases, from 40 years ago when it was found and isolated, Ubidecarenone has been conducted hundreds of clinical studies, a lot of evidence shows that nutrition is necessary for health (health food) .
Ubiquinone / Coenzyme Q10, commonly known as Coenzyme Q10 or CoQ10, is a naturally occurring lipid-soluble benzoquinone compound that participates in cellular energy production and antioxidant defense.
It is also known as CoQ10, Q10, ubiquinone-10, ubidecarenone, and vitamin Q10.
Ubiquinone / Coenzyme Q10 has the molecular formula C59H90O4 and a molecular weight of approximately 863.3 g/mol.
The “10” in its name refers to the ten isoprenoid units forming its long hydrophobic side chain.
The molecule consists of a substituted benzoquinone ring connected to a long polyisoprenoid side chain.
This structure gives CoQ10 a strongly lipophilic character and allows it to associate closely with biological membranes.
Ubiquinone / Coenzyme Q10 occurs naturally throughout the body and is present in particularly important concentrations in tissues and cellular structures with high energy requirements.
The human body can synthesize CoQ10 endogenously, while smaller amounts can also be obtained from dietary sources.
The principal biochemical role of CoQ10 is associated with the mitochondrial electron transport chain.
Ubiquinone / Coenzyme Q10 transfers electrons between respiratory-chain complexes and contributes to the generation of the proton gradient required for ATP production.
Ubiquinone / Coenzyme Q10 exists in two interconvertible redox forms, the oxidized form known as ubiquinone and the reduced form known as ubiquinol.
These two forms participate in a continuous oxidation-reduction cycle within biological membranes.
Ubiquinone / Coenzyme Q10 is particularly important for the antioxidant function of the CoQ10 system.
The reduced form can help protect membrane lipids from oxidative damage and can participate in the regeneration of other antioxidant molecules such as vitamin E.
Although the terms Coenzyme Q10 and ubiquinone are frequently used interchangeably, Coenzyme Q10 technically describes the CoQ10 redox system, while ubiquinone refers specifically to its oxidized form.
This distinction becomes relevant when comparing CoQ10 supplements and cosmetic raw materials because products may contain either ubiquinone or the reduced form, ubiquinol.
Ubiquinone / Coenzyme Q10 is highly lipophilic and has very limited water solubility.
Ubiquinone / Coenzyme Q10s long isoprenoid chain strongly favors incorporation into lipid phases, biological membranes, oils, and other hydrophobic environments rather than aqueous systems.
The lipophilic structure also influences how CoQ10 is formulated in pharmaceutical, nutritional, and cosmetic products.
Oil-based carriers, emulsions, lipid particles, and other delivery systems can be used to improve its dispersion and bioavailability.
Ubiquinone / Coenzyme Q10 is naturally present in human skin, where it contributes to cellular energy metabolism and protection against oxidative stress.
Studies have reported that the amount of CoQ10 in skin can decrease with age and can also be affected by external environmental stressors.
Ubiquinone / Coenzyme Q10 has become an important ingredient in cosmetic products intended for mature or environmentally stressed skin.
Topical studies have shown that CoQ10-containing formulations can increase CoQ10 levels in the skin and provide measurable antioxidant effects.
Ubiquinone / Coenzyme Q10 is particularly associated with anti-aging skincare because oxidative stress is one of the factors involved in the development of visible skin aging.
Research has investigated its effects on wrinkles, skin roughness, cellular oxidative damage, and other characteristics associated with photoaging.
Topically applied Ubiquinone / Coenzyme Q10 can penetrate into the epidermis rather than remaining exclusively on the surface of the skin.
Experimental studies have detected increased ubiquinone levels in deeper epidermal layers following application of CoQ10-containing formulations.
Ubiquinone / Coenzyme Q10 has also been investigated for its potential role in protecting skin cells against ultraviolet-associated oxidative stress.
Experimental research has reported reductions in oxidative damage and changes in cellular processes associated with photoaging following CoQ10 exposure.
In cosmetic science, CoQ10 is therefore primarily valued as a lipophilic antioxidant and skin-conditioning active.
Ubiquinone / Coenzyme Q10 is frequently incorporated into formulations designed to support the appearance of mature skin, reduce visible signs of oxidative stress, and maintain a smoother-looking complexion.
Research has additionally examined CoQ10 in relation to skin inflammation and pigmentation pathways.
Laboratory studies have reported effects on inflammatory mediators, reactive oxygen species, tyrosinase activity, and melanogenesis, although these findings should be distinguished from established clinical treatment effects.
The stability and delivery of CoQ10 are important considerations because its highly hydrophobic structure makes direct incorporation into water-based formulations difficult.
Consequently, emulsification, encapsulation, lipid carriers, and other formulation technologies are frequently investigated to improve its distribution and performance.
Ubiquinone / Coenzyme Q10 is consequently used across nutritional, pharmaceutical, and cosmetic fields, with applications based primarily on its role in cellular energy metabolism and redox protection.
In personal-care formulations, its most established positioning is as an antioxidant and anti-aging ingredient for products targeting mature, dry, or environmentally stressed skin.
Melting point: 49-51 °C
Boiling point: 715.32 °C (rough estimate)
Density: 0.9145 (rough estimate)
Refractive index: 1.4760 (estimate)
Storage temp.: -20 °C
Solubility: Soluble in chloroform.
Form: Solid
Color: Light Orange to Dark Orange
Biological source: Synthetic
Sensitive: Light Sensitive
Merck: 14,9843
BRN: 1900141
Stability: Stable, but may be light or heat sensitive. Store in the dark at -20 °C. Incompatible with strong oxidizing agents.
Major Application: Cleaning products; cosmetics; food and beverages; personal care
Cosmetics Ingredients Functions: ANTIOXIDANT; SKIN CONDITIONING
InChIKey: ACTIUHUUMQJHFO-DQXDOXBUSA-N
SMILES: O=C(C(OC)=C1OC)C(C/C=C(C)/CC/C=C(CC/C=C(CC/C=C(CC/C=C(CC/C=C(CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)\C)\C)\C)\C)\C)=C(C)C1=O
LogP: 19.119 (est)
Ubiquinone / Coenzyme Q10 is a ubiquinone having a side chain of 10 isoprenoid units.
In the naturally occurring isomer, all isoprenyl double bonds are in the E- configuration.
Ubiquinone / Coenzyme Q10 has a role as a human metabolite, a ferroptosis inhibitor and an antioxidant.
Ubiquinone / Coenzyme Q10 is found in animal organs and yeast with active in the citric acid cycle in carbohydrate metabolism.
Ubiquinone / Coenzyme Q10 is a fat-soluble compound primarily synthesised by the body and also consumed in the diet.
Ubiquinone / Coenzyme Q10 is a physiological element present in the cells as a component of the mitochondrial respiratory chain.
Ubiquinone / Coenzyme Q10 is involved in the process of energy production by mitochondria and functions as an antioxidant in cell membranes and lipoproteins.
It acts directly on the oxidative phosphorylation processes for the production of energy (formation of ATP) through metabolic, especially aerobical, pathways.
Ubiquinone / Coenzyme Q10, referred to as coenzyme Q, is abundantly available in human cells, with major proportions being present in vital body organs such as heart and kidneys.
Ubiquinone / Coenzyme Q10 plays an important role in cell metabolism owing to its significant contribution to the electron transport pathway.
Ubiquinone / Coenzyme Q10 is a strong antioxidant and acts as an essential enzyme catalyst in mitochondrial oxidative phosphorylation.
Ubiquinone / Coenzyme Q10 is a 1,4-benzoquinone, where Q refers to the quinone chemical group, and 10 refers to the number of isoprenyl chemical subunits in its tail.
This oil-soluble, vitamin-like substance is found in all cells as part of the electron transfer chain responsible for energy production and provides 95% of the body’s energy in the form of ATP.
There are three redox states of coenzyme Q10: fully oxidized (ubiquinone), semiquinone (ubisemiquinone), and fully reduced (ubiquinol).
A natural resource of coenzyme Q10 is fish and shellfish although animal’s foods such heart will have very high concentrations reflecting mitochondrial levels in such tissue (Crane, 2001).
Ubiquinone / Coenzyme Q10 has been used to reduce wrinkles (changes in the dermal matrix), reduce cell death and DNA oxidative stress, increase ATP systhesis, and suppress collagenase following UVA irradiation.
Ubiquinone / Coenzyme Q10 is also important because its quinone ring can undergo reversible one- and two-electron reduction reactions.
This allows CoQ10 to continuously cycle between oxidized ubiquinone and reduced ubiquinol during cellular metabolism.
The same redox chemistry enables CoQ10 to function as an electron carrier and contributes to its antioxidant activity in biological membranes.
The long isoprenoid chain of Ubiquinone / Coenzyme Q10 makes the molecule highly hydrophobic and strongly associated with lipid environments.
This structure allows it to move within biological membranes and interact with other membrane-associated components of the respiratory chain.
Ubiquinone / Coenzyme Q10s pronounced lipophilicity also explains why CoQ10 has very limited compatibility with purely aqueous formulations.
Ubiquinone / Coenzyme Q10 acts as a mobile electron carrier between different components of the electron transport chain.
Ubiquinone / Coenzyme Q10 accepts electrons from respiratory complexes and transfers them toward downstream components involved in oxidative phosphorylation.
This electron-transfer process contributes to the proton gradient that ultimately supports ATP synthesis.
Ubiquinone / Coenzyme Q10 is not limited to mitochondrial membranes and is distributed throughout cellular membranes and lipid compartments.
Ubiquinone / Coenzyme Q10 antioxidant activity is particularly relevant in membranes because it can participate in protection against lipid peroxidation.
The reduced ubiquinol form can also participate in the regeneration of other lipid-soluble antioxidants, including vitamin E.
Ubiquinone / Coenzyme Q10 in human skin changes with age and can also be affected by environmental stress.
Ubiquinone / Coenzyme Q10 has found that topical application of CoQ10 can increase measurable CoQ10 levels both on the skin surface and within epidermal layers.
This has contributed to the development of CoQ10-containing skincare products intended to support antioxidant protection and the appearance of aging skin.
Ubiquinone / Coenzyme Q10 is particularly relevant to cosmetic formulations designed for mature skin because oxidative stress is one of several factors associated with visible skin aging.
Topical studies have investigated its effects on wrinkles, skin roughness, oxidative stress, and other parameters associated with skin aging.
Clinical and experimental findings provide evidence for cosmetic anti-aging applications, although the magnitude of effects depends on formulation and study conditions.
Ubiquinone / Coenzyme Q10 has also been investigated for its potential photoprotective properties in skin.
Experimental research has examined its ability to reduce oxidative effects associated with ultraviolet exposure and environmental stressors.
Ubiquinone / Coenzyme Q10 should nevertheless be regarded as a cosmetic antioxidant rather than a substitute for established sunscreen protection.
Another area of research concerns the interaction between Ubiquinone / Coenzyme Q10 and inflammatory processes in skin.
Studies have reported effects on reactive oxygen species and inflammatory signaling molecules in experimental models exposed to ultraviolet stress.
These findings have encouraged investigation of CoQ10 as a supporting ingredient in formulations designed for environmentally stressed skin.
Ubiquinone / Coenzyme Q10 has also attracted interest in cosmetic pigmentation research.
In vitro studies have reported inhibition of tyrosinase activity and effects on melanogenesis under experimental conditions.
These findings provide a scientific basis for investigating CoQ10 in products intended to support a more even-looking skin tone, although laboratory findings do not by themselves establish a clinical depigmenting effect.
The formulation of CoQ10 can be challenging because its strong hydrophobicity limits direct dispersion in water.
For this reason, manufacturers may use oils, emulsions, solubilization systems, lipid carriers, or encapsulation technologies when developing CoQ10-containing products.
Advanced delivery systems such as solid lipid nanoparticles and nanostructured lipid carriers have been investigated to improve its chemical stability, skin absorption, and bioavailability.
Ubiquinone / Coenzyme Q10 is also sensitive to formulation conditions because its redox-active quinone structure can participate in oxidation-reduction reactions.
The surrounding lipid environment, formulation composition, packaging, and storage conditions can therefore influence the stability of CoQ10-containing products.
Encapsulation and lipid-based delivery systems are being investigated partly to provide greater protection and more controlled delivery of the active ingredient.
In nutritional products, Ubiquinone / Coenzyme Q10 is available primarily as ubiquinone or ubiquinol.
Ubiquinone is the oxidized form, whereas ubiquinol represents the fully reduced form of the same CoQ10 redox system.
Both forms participate in the biological CoQ10 cycle, although their formulation characteristics and absorption profiles can differ.
Ubiquinone / Coenzyme Q10 can be obtained through endogenous biosynthesis as well as dietary sources.
The body synthesizes the molecule through a multistep pathway that produces both the quinone head group and its long isoprenoid side chain.
Because this biosynthetic pathway is present in human cells, CoQ10 is considered an endogenous compound rather than a conventional dietary vitamin.
The term “ubiquinone” reflects the widespread distribution of this type of quinone compound across living organisms.
Different organisms can produce CoQ molecules with different numbers of isoprenoid units, while CoQ10 is the predominant form in humans.
The number of isoprenoid units is represented by the numerical designation following “CoQ.”
Ubiquinone / Coenzyme Q10 is therefore a multifunctional molecule combining electron-transfer activity, lipid-membrane localization, and antioxidant properties.
These characteristics explain its importance in mitochondrial energy metabolism as well as its continued investigation in dermatology, cosmetics, nutrition, and pharmaceutical research.
In cosmetic raw materials, its principal functional positioning is as a lipophilic antioxidant and skin-conditioning ingredient, particularly in anti-aging and environmentally stressed skin formulations.
Ubiquinone / Coenzyme Q10 can reduce myocardial contractility decrease , reduce creatine phosphate and ATP content decrease in acute ischemia, maintaining morphology of ischemic myocardium mitochondria, having a protective effect for myocardial ischemia.
Ubiquinone / Coenzyme Q10 can increase cardiac output, reduced peripheral resistance, conducive to anti-heart failure treatment, may inhibit the synthesis and secretion of aldosterone, and block its effects on the kidney tubules.
Under hypoxic conditions in vitro perfusion animals ventricular muscle, it can shorten the duration of the action potential, resulting in ventricular arrhythmia threshold than the control animals.
Ubiquinone / Coenzyme Q10 can decrease peripheral vascular resistance, and owns anti-aldosterone effect.
Ubiquinone / Coenzyme Q10 owns anti-cardiotoxic effects and hepatoprotective effect of doxorubicin.
Uses Of Ubiquinone / Coenzyme Q10:
Ubiquinone / Coenzyme Q10 is also an important antioxidant and immune enhancer.
For congestive heart failure, arrhythmias, sinus tachycardia, premature beats, hypertension and cancer adjuvant therapy for acute and chronic viral hepatitis and subacute hepatic necrosis comprehensive treatment.
In addition, it is also tested in primary and secondary aldosteronism, cerebrovascular disorders and hemorrhagic shock during the application, user may appear nausea, upset stomach, loss of appetite and other phenomena, urticaria, and a transient palpitations occasionally appear.
Ubiquinone / Coenzyme Q10 can be widely used in food, cosmetics, dietary supplements and other industries. Coenzyme drugs, is also an important antioxidant and immune enhancer.
Ubiquinone / Coenzyme Q10 can activate human cells and cellular energy nutrition, it can improve human immunity, enhance anti-oxidation, anti-aging and enhance human activity.
In addition, recent studies indicate that the product also has anti-tumor effects, for advanced metastatic cancer have a certain effect in clinical, have a significant effect in the prevention of coronary heart disease, alleviate periodontitis, treatment of duodenal and gastric ulcer, strengthen the immune system function and relieve angina .
Because Ubidecarenone is effective and without side effects.
Ubiquinone / Coenzyme Q10 is used in pharmaceuticals, cosmetics, food additives and other industries.
Ubiquinone / Coenzyme Q10 is a naturally occurring quinone found throughout the body in cell membranes, primarily in mitochondrial membranes, with highest concentrations in the heart, lungs, liver, kidneys, spleen, pancreas, and adrenal glands.
It is a component of the electron transport chain and participates in aerobic cellular respiration, generating energy in the form of ATP.
In its reduced form, CoQ10 acts as an antioxidant, preventing the formation of reactive oxygen species.
Ubiquinone / Coenzyme Q10 deficiencies have been associated with heart failure, hypertension, parkinsonism, mitochondrial encephalomyopathies, and other chronic diseases.
Ubiquinone / Coenzyme Q10 is widely used in cosmetic skincare formulations as an antioxidant active.
Ubiquinone / Coenzyme Q10s ability to participate in redox reactions and protect lipid structures from oxidative damage makes it suitable for products designed to support the skin's natural antioxidant defenses.
It is particularly common in formulations marketed for mature and environmentally stressed skin.
Ubiquinone / Coenzyme Q10 is extensively used in anti-aging creams and facial moisturizers.
Topical studies have reported increased CoQ10 levels in the skin following application and have investigated improvements in wrinkles, roughness, and other visible signs of aging.
This makes CoQ10 a common active ingredient in daily skincare products targeting age-associated changes.
Ubiquinone / Coenzyme Q10 is also incorporated into anti-wrinkle and skin-rejuvenating formulations.
Research has found that topical CoQ10 can reach living epidermal layers and has been associated with reductions in wrinkle depth in clinical and experimental studies.
These properties support its use in products formulated to improve the appearance of fine lines and uneven skin texture.
Ubiquinone / Coenzyme Q10 is used in facial serums designed to deliver concentrated antioxidant ingredients to the skin.
Because ubiquinone is strongly lipophilic, formulation systems containing oils, emulsifiers, or specialized carriers can be used to distribute it effectively through serum formulations.
Studies have specifically evaluated CoQ10-containing serum and cream formulations for topical skin delivery.
Ubiquinone / Coenzyme Q10 is also used in eye-area creams and anti-aging products.
The ingredient has been investigated for its effects on wrinkles around the eyes and other visible characteristics of mature skin.
This application is particularly associated with formulations intended to improve the appearance of fine lines and skin roughness around the periorbital region.
Ubiquinone / Coenzyme Q10 can be included in neck, décolletage, hand, and body-care products formulated for visibly aged or environmentally stressed skin.
These areas can show changes in elasticity, roughness, and wrinkle formation, creating applications for antioxidant and anti-aging ingredients such as CoQ10.
Topical studies have investigated CoQ10-containing products on areas including the neck, forearms, hands, and décolletage.
Another important application is in skin-conditioning formulations for dry or stressed skin.
Ubiquinone / Coenzyme Q10-containing products have been studied for their ability to increase antioxidant capacity and improve skin moisturization measurements.
This allows the ingredient to be incorporated into products where antioxidant protection is combined with hydration and skin-conditioning functions.
Ubiquinone / Coenzyme Q10is also used in cosmetic products designed to protect skin from environmental oxidative stress.
Research has investigated its ability to reduce oxidative effects associated with reactive oxygen species and ultraviolet exposure.
For this reason, CoQ10 is often positioned as a supporting antioxidant in formulations intended for environmentally exposed skin.
Ubiquinone / Coenzyme Q10 can be incorporated into photoprotective skincare formulations as an antioxidant component.
Experimental studies have examined CoQ10-loaded delivery systems for their potential to reduce oxidative damage associated with ultraviolet radiation.
Ubiquinone / Coenzyme Q10 is an antioxidant cosmetic ingredient and should not be considered a replacement for sunscreen filters in products requiring UV protection.
Ubiquinone / Coenzyme Q10 is also investigated for use in skin-brightening and pigmentation-focused formulations.
In vitro research has reported inhibition of tyrosinase activity and effects on melanogenesis, providing a basis for studying CoQ10 in products intended to improve the appearance of uneven pigmentation.
These findings remain primarily mechanistic and experimental rather than establishing CoQ10 as a clinically established treatment for pigmentation disorders.
Another application is in formulations targeting oxidative stress associated with skin aging.
Ubiquinone / Coenzyme Q10 can support the skin's antioxidant system while participating in cellular energy metabolism.
This dual functionality is one reason it is incorporated into products intended to maintain the appearance and function of mature skin.
Ubiquinone / Coenzyme Q10 is also used in lipid-based cosmetic delivery systems.
Ubiquinone / Coenzyme Q10s strong lipophilicity allows it to be incorporated into oil phases, emulsions, and lipid-rich carriers that can improve its distribution in topical products.
These systems are particularly useful when formulating CoQ10 for water-containing creams, lotions, and serums.
Ubiquinone / Coenzyme Q10 is being investigated in solid lipid nanoparticles and nanostructured lipid carriers for topical applications.
These systems are designed to improve the chemical stability, skin absorption, and delivery of poorly water-soluble antioxidants such as CoQ10.
Such technologies remain an important area of research for advanced cosmetic and dermatological formulations.
Ubiquinone / Coenzyme Q10 is also used in liposomal and other encapsulated delivery systems developed for cosmetic and pharmaceutical research.
Encapsulation can help disperse the highly lipophilic molecule and may provide controlled release or improved deposition within the skin.
These approaches are being explored to overcome some of the formulation limitations associated with conventional CoQ10 preparations.
Ubiquinone / Coenzyme Q10 is widely marketed as a dietary supplement.
Ubiquinone / Coenzyme Q10 products are available primarily in ubiquinone and ubiquinol forms and are used to supplement endogenous CoQ10 levels.
Research has investigated supplementation in cardiovascular health, mitochondrial function, and other areas, although the strength of evidence varies substantially between applications.
Ubiquinone / Coenzyme Q10 supplementation has been studied as an adjunctive approach in cardiovascular conditions, including heart failure and hypertension.
Clinical research has examined outcomes such as cardiac function, blood pressure, endothelial function, and exercise capacity.
The evidence is application-specific, so these research uses should not be interpreted as establishing CoQ10 as a general treatment for cardiovascular disease.
Ubiquinone / Coenzyme Q10 is also investigated in relation to statin-associated muscle symptoms because statin therapy can reduce circulating CoQ10 concentrations.
Clinical studies have produced mixed findings regarding whether supplementation reduces muscle symptoms, and routine supplementation for all statin users has not been established on the basis of this evidence.
Consequently, this remains a research and clinical-evaluation area rather than a universal indication for CoQ10 supplementation.
In the pharmaceutical and nutraceutical industries, CoQ10 is therefore used as a lipid-soluble bioactive ingredient in oral capsules, softgels, powders, and specialized delivery systems.
Its formulation into lipid-based systems is particularly relevant because conventional CoQ10 has very low water solubility.
Different delivery technologies are consequently developed to improve dispersion and absorption of the active compound.
Ubiquinone / Coenzyme Q10 is also used as a research compound in studies of mitochondrial energy metabolism and oxidative stress.
Ubiquinone / Coenzyme Q10s central role in electron transport makes it useful for investigating cellular bioenergetics, mitochondrial dysfunction, and redox processes.
These research applications extend beyond its commercial roles in cosmetics and nutritional products.
Ubiquinone / Coenzyme Q10 is also known as coenzyme Q10 it is a powerful antioxidant that is naturally found in the cells. It acts as a free radical neutraliser.
Safety Profile Of Ubiquinone / Coenzyme Q10:
Ubiquinone / Coenzyme Q10 is generally considered to have low toxicity when used at customary dietary-supplement levels.
Human and animal safety data have not identified serious toxicity as a typical consequence of CoQ10 exposure.
A long-term safety assessment concluded that CoQ10 has a broad safety margin based on available toxicological and clinical data.
The most commonly reported adverse effects of orally administered CoQ10 are relatively mild gastrointestinal symptoms.
These can include nausea, abdominal discomfort, diarrhea, reduced appetite, and other digestive disturbances.
Such effects are generally uncommon and have not consistently shown a dose-dependent relationship in clinical studies.
Insomnia or sleep disturbance has also been reported in some people taking CoQ10 supplements.
The available safety information indicates that these effects are generally mild rather than severe.
Individuals who experience persistent sleep problems after starting supplementation may need to reconsider the timing or continued use of the product with appropriate professional advice.
Headache, dizziness, fatigue, heartburn, and upper abdominal discomfort have also been reported during CoQ10 use.
These reactions have generally been described as mild and are not considered characteristic severe toxic effects of the compound.
Individual tolerance can nevertheless vary between users and between different CoQ10 formulations.
Ubiquinone / Coenzyme Q10 Procurement and Technical Support:
Ataman Kimya supports customers looking for Ubiquinone / Coenzyme Q10 with dependable supply solutions and relevant technical information for industrial and formulation requirements.
Additional support can be provided regarding product specifications, available documentation, and the evaluation of suitable product options based on the intended application.
